Dynamic Medical Technologies
Dynamic Medical Technologies Inc., together with its subsidiaries, engages in the sale, maintenance, and marketing of aesthetic lasers and light-based equipment in Taiwan and Hong Kong. It distributes and sells aesthetic medical devices, body contouring devices, dermal fillers, and cosmeceuticals. The company also provides aesthetician training and clinical operation consultation services. In add… Read more
Dynamic Medical Technologies (4138) - Net Assets
Latest net assets as of September 2025: NT$1.81 Billion TWD
Based on the latest financial reports, Dynamic Medical Technologies (4138) has net assets worth NT$1.81 Billion TWD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$2.98 Billion) and total liabilities (NT$1.17 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$1.81 Billion |
| % of Total Assets | 60.79% |
| Annual Growth Rate | 2.84% |
| 5-Year Change | 20.25% |
| 10-Year Change | N/A |
| Growth Volatility | 3.19 |
Dynamic Medical Technologies - Net Assets Trend (2016–2024)
This chart illustrates how Dynamic Medical Technologies's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Dynamic Medical Technologies (2016–2024)
The table below shows the annual net assets of Dynamic Medical Technologies from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$1.76 Billion | +3.26% |
| 2023-12-31 | NT$1.70 Billion | +9.65% |
| 2022-12-31 | NT$1.55 Billion | +5.58% |
| 2021-12-31 | NT$1.47 Billion | +0.60% |
| 2020-12-31 | NT$1.46 Billion | -0.34% |
| 2019-12-31 | NT$1.47 Billion | +2.45% |
| 2018-12-31 | NT$1.43 Billion | +2.53% |
| 2017-12-31 | NT$1.40 Billion | -0.61% |
| 2016-12-31 | NT$1.41 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Dynamic Medical Technologies's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 43.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$250.67 Million | 16.32% |
| Other Components | NT$1.29 Billion | 83.68% |
| Total Equity | NT$1.54 Billion | 100.00% |
Dynamic Medical Technologies Competitors by Market Cap
The table below lists competitors of Dynamic Medical Technologies ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
EgnsINVEST Ejendomme Tyskland A/S
CO:EGNETY
|
$39.41 Million |
|
E3 Metals Corp
OTCQX:EEMMF
|
$39.42 Million |
|
Tasty Bite Eatables Limited
NSE:TASTYBITE
|
$39.42 Million |
|
MIC Electronics Limited
NSE:MICEL
|
$39.42 Million |
|
Perfect Corp.
NYSE:PERF
|
$39.41 Million |
|
Texaf S.A.
LSE:0Q5Q
|
$39.41 Million |
|
INFOM
KLSE:0265
|
$39.41 Million |
|
Punjab Chemicals & Crop Protection Limited
NSE:PUNJABCHEM
|
$39.40 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Dynamic Medical Technologies's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,536,011,000 to 1,536,283,000, a change of 272,000 (0.0%).
- Net income of 205,393,000 contributed positively to equity growth.
- Dividend payments of 222,750,000 reduced retained earnings.
- Other comprehensive income decreased equity by 293,981,000.
- Other factors increased equity by 311,610,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$205.39 Million | +13.37% |
| Dividends Paid | NT$222.75 Million | -14.5% |
| Other Comprehensive Income | NT$-293.98 Million | -19.14% |
| Other Changes | NT$311.61 Million | +20.28% |
| Total Change | NT$- | 0.02% |
Book Value vs Market Value Analysis
This analysis compares Dynamic Medical Technologies's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.62x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.89x to 1.62x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | NT$33.01 | NT$62.30 | x |
| 2017-12-31 | NT$30.97 | NT$62.30 | x |
| 2018-12-31 | NT$38.35 | NT$62.30 | x |
| 2019-12-31 | NT$35.14 | NT$62.30 | x |
| 2020-12-31 | NT$38.92 | NT$62.30 | x |
| 2021-12-31 | NT$38.71 | NT$62.30 | x |
| 2022-12-31 | NT$41.87 | NT$62.30 | x |
| 2023-12-31 | NT$46.37 | NT$62.30 | x |
| 2024-12-31 | NT$38.47 | NT$62.30 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Dynamic Medical Technologies utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 13.37%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 13.06%
- • Asset Turnover: 0.52x
- • Equity Multiplier: 1.96x
- Recent ROE (13.37%) is above the historical average (10.13%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 9.41% | 9.75% | 0.54x | 1.80x | NT$-7.48 Million |
| 2017 | 9.21% | 9.78% | 0.50x | 1.88x | NT$-9.76 Million |
| 2018 | 8.26% | 9.01% | 0.58x | 1.59x | NT$-22.15 Million |
| 2019 | 8.78% | 9.55% | 0.53x | 1.74x | NT$-15.65 Million |
| 2020 | 8.99% | 11.49% | 0.47x | 1.66x | NT$-13.10 Million |
| 2021 | 9.60% | 11.98% | 0.45x | 1.79x | NT$-5.20 Million |
| 2022 | 9.88% | 10.61% | 0.48x | 1.93x | NT$-1.66 Million |
| 2023 | 13.69% | 13.20% | 0.52x | 2.00x | NT$56.72 Million |
| 2024 | 13.37% | 13.06% | 0.52x | 1.96x | NT$51.76 Million |
Industry Comparison
This section compares Dynamic Medical Technologies's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,220,290,556
- Average return on equity (ROE) among peers: 5.99%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Dynamic Medical Technologies (4138) | NT$1.81 Billion | 9.41% | 0.65x | $39.41 Million |
| Health & Life Co., Ltd. (1781) | $372.58 Million | -4.71% | 1.15x | $12.97 Million |
| Hi-Clearance (1788) | $3.00 Billion | 11.98% | 0.65x | $104.25 Million |
| Radiant Innovation (3373) | $865.89 Million | -3.30% | 0.08x | $18.65 Million |
| Wellell Inc (4106) | $1.31 Billion | 13.81% | 0.24x | $37.12 Million |
| Rossmax International Ltd (4121) | $1.33 Billion | 1.93% | 1.30x | $38.32 Million |
| United Orthopedic (4129) | $1.77 Billion | 7.55% | 0.46x | $300.33 Million |
| Ok Biotech Co Ltd (4155) | $1.30 Billion | 9.66% | 0.71x | $44.61 Million |
| Bioptik Technology (4161) | $717.83 Million | 6.76% | 1.11x | $30.42 Million |
| EPS Bio Technology Corp. (4183) | $309.15 Million | 10.25% | 0.77x | $4.27 Million |